Quest Diagnostics (DGX) Change in Receivables (2009 - 2026)

Quest Diagnostics has reported Change in Receivables for 18 years, with the latest figure at $79.0 million in Q2 2026.

• Quarterly Change in Receivables rose 464.29% year-over-year to $79.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $250.0 million (up 242.47% YoY) and the FY2025 annual result came in at $106.0 million, up 49.3% from the prior year.
• Change in Receivables retreated to $79.0 million in Q2 2026 per DGX's latest filing, from $180.0 million in the prior quarter.
• Over five years, Change in Receivables peaked at $180.0 million in Q1 2026 and troughed at -$84.0 million in Q4 2022.
• A 5-year average of $11.4 million and a median of $6.5 million in 2024 frame the typical range for Change in Receivables.
• The sharpest annual moves came in 2022 and 2025: Change in Receivables slumped 133.33% in 2022, then soared 1500.0% in 2025.
• Over 5 years, Change in Receivables stood at -$84.0 million in 2022, then rose by 15.48% to -$71.0 million in 2023, then gained by 2.82% to -$69.0 million in 2024, then jumped by 31.88% to -$47.0 million in 2025, then soared by 268.09% to $79.0 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered $79.0 million, $180.0 million, and -$47.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.